EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review

Janis Chang, Aliyah King iD, Adam Byrne, Carmen Liy-Wong iD

Pediatric Dermatology · 2026-03 · 43 (2) · 411-414

DOI: 10.1111/pde.70038 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, online erschienen am 08.10.2025. Verfasst von Janis Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Omalizumab, Mastocytosis, Cutaneous, Anti-Allergic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report an 11‐month‐old boy with diffuse cutaneous mastocytosis whose severe pruritus and steroid dependence resolved following off‐label treatment with omalizumab. A literature review identified five additional pediatric cases in which omalizumab led to complete symptom resolution in an average of 2 months and permitted discontinuation of systemic steroids. Although limited by the small sample size and lack of high‐quality data, omalizumab presents as a well‐tolerated and potentially effective steroid‐sparing agent for pediatric cutaneous mastocytosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OmalizumabMastocytosis, CutaneousAnti-Allergic AgentsHumansMaleInfantTreatment Outcome

Stichwörter der Autor:innen

case reportmastocytosisomalizumabpediatricssystematic reviewtherapeutic

Substanzen

OmalizumabAnti-Allergic Agents

Autor:innen und Institutionen

  • Division of Dermatology, The Ottawa Hospital and University of Ottawa, Ottawa, Canada.
  • Department of Medicine, University of Ottawa, Ottawa, Canada.
  • Division of Infectious Diseases, Allergy, and Immunology, Department of Pediatrics, University of Ottawa, Ottawa, Canada.
  • Division of Dermatology and Rheumatology, Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, Canada.

ORCID-Profile: Aliyah King, Carmen Liy-Wong

Zitieren

APA

Chang, J., King, A., Byrne, A., & Liy-Wong, C. (2026). Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review. Pediatric Dermatology, 43(2), 411-414. https://doi.org/10.1111/pde.70038

Vancouver

Chang J, King A, Byrne A, Liy-Wong C. Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review. Pediatric Dermatology. 2026;43(2):411-414. doi:10.1111/pde.70038

BibTeX
@article{Chang2026,
  author = {Chang, Janis and King, Aliyah and Byrne, Adam and Liy-Wong, Carmen},
  title = {Omalizumab for Pediatric Cutaneous Mastocytosis: Case Report and Review},
  journal = {Pediatric Dermatology},
  year = {2026},
  volume = {43},
  number = {2},
  pages = {411--414},
  doi = {10.1111/pde.70038}
}
Kostenlos starten →